Chapter 9 - Emma Learns That Safety Can Become Another Kind of Control
Seven years after Chicago, I was no longer spending half my week at the bedside.
I was Director of Clinical Safety for a regional hospital and home-health network.
That title sounded more powerful than it felt.
Most days I sat in rooms where everyone knew something had gone wrong and nobody agreed what kind of wrong it was.
Medication events.
Falls.
Delayed diagnoses.
Privacy breaches.
Communication failures.
Near misses.
I still worked one clinical shift every few months because I did not want my understanding of nursing to become purely retrospective.
Then an insulin case landed on my desk.
Of course it did.
A seventy-nine-year-old home-health patient, Raymond Cole, had experienced recurrent morning hypoglycemia.
He had type 2 diabetes.
His prescribed regimen:
long-acting insulin at night,
no rapid-acting insulin,
continuous glucose monitor.
A home-health nurse reported finding an unlisted lispro pen in the refrigerator.
My whole body reacted before my brain did.
Insulin pen.
Unlisted medication.
Older patient.
Home setting.
I ordered an immediate safety hold on all medication administration by one of the family caregivers pending review.
Too fast.
The caregiver was Raymond’s wife, June.
She was sixty-eight and had type 1 diabetes.
The lispro pen belonged to her.
Properly prescribed.
Clearly labeled.
Stored in a separate bin that the nurse had moved while cleaning space for groceries.
No one had given Raymond lispro.
His hypoglycemia came from something else:
his long-acting insulin dose had not been reduced after a fifteen-pound weight loss and declining appetite.
The visiting nurse had documented poor intake twice.
The primary-care office had received the message but no clinician acted before the next dose cycle.
I had seen the suspicious pen and jumped.
No patient harm came from my safety hold.
But June felt accused.
She said:
“You looked at my insulin and decided I was poisoning my husband.”
I wanted to defend myself.
I said:
“I decided too quickly that the pen might be involved.”
“That’s not what I said.”
She was right.
I had also restricted her from helping Raymond with medications for twelve hours.
I said:
“I’m sorry.”
Then:
“You had a right to ask whose pen it was before we changed your role.”
She nodded.
Not forgiving me theatrically.
Then the review.
Root cause:
insulin dose not reassessed after weight loss,
home-health messages fragmented across EHR inbox,
no clear owner for diabetes medication adjustment,
CGM lows acknowledged but not escalated under existing threshold.
The stray lispro pen was incidental.
That case embarrassed me.
Good.
Patient-safety leaders are dangerous if they start believing every past experience is prophecy.
I changed our home-health investigation checklist:
First:
identify patient-specific medications and other household members’ medications separately.
Second:
verify labels before assuming possession equals administration.
Third:
do not restrict capable family support unless evidence or immediate safety risk justifies it.
Fourth:
still escalate unexplained hypoglycemia promptly.
Not softer.
More accurate.
Then I told my team why I had overreacted.
Not full Moretti story.
They knew public version anyway.
“I have a history that makes unexplained insulin exposure salient to me. That is useful and also a bias.”
There.
Leaders should disclose relevant bias when it affects decisions.
Then my mother.
Margaret was eighty-one.
Still living alone.
More slowly.
She had fallen twice in one year.
No major injury.
This time, I did not arrive with a binder.
We talked.
She said:
“I’m not moving.”
“Okay.”
Then:
“I might accept someone twice a week.”
Good.
We hired a home-care aide through an agency.
My mother interviewed.
Chose.
The aide, Tasha Green, helped with:
groceries,
laundry,
transportation,
shower safety if requested.
Not medication management.
Margaret still managed her pills with a weekly organizer.
Then one day she missed two doses of blood-pressure medication.
I panicked.
“Maybe I should take over the pillbox.”
She glared.
“Maybe you should ask whether I want help.”
There.
At eighty-one, she was still teaching me.
We compromised:
pharmacy blister packs.
Tasha reminded but did not administer.
My mother remained in control.
Then Aunt Helen.
She died at eighty-six after years with dementia.
Quietly.
Pneumonia.
No dramatic lucid moment.
I sat with my mother at the funeral home.
Helen’s memory-care years had drained money and energy, but they had also given her safety and companionship.
No simple verdict:
home good,
facility bad.
Systems are judged by actual care.
Then finances.
Without Helen’s extra costs, my mother’s budget eased.
My salary had improved too.
I no longer worked three jobs.
I started contributing more to retirement.
I took a vacation.
Alone.
Maine.
My mother said:
“You finally learned money can be used for something besides emergencies.”
Maybe.
Then relationships.
I had dated a physical therapist, Aaron Blake, for two years.
We broke up because:
he wanted to move to Arizona,
I did not.
No betrayal.
No Moretti interference.
Then I dated no one for a while.
No narrative problem.
At forty-four, I did not feel unfinished.
Then one day Luca’s name appeared in my work inbox.
Not from him.
Moretti Hospitality had submitted a proposal to our health network’s lodging program for discounted extended-stay rooms for families of hospitalized patients.
My staff member asked:
“You know him, right?”
“I was his nurse seven years ago.”
“Should you review?”
“No.”
Conflict.
I recused from vendor scoring.
Another director handled.
Moretti’s proposal was not the cheapest.
It scored well on:
accessibility,
transport,
flexible cancellation,
but worse on:
price and geographic coverage.
They won two locations, lost three.
Normal procurement.
I did not call Luca.
He did not call me.
Good.
Then he sent one professional note after contracts were public:
I saw your network is using two of our properties. I assume you had nothing to do with it.
I replied:
Correct. I recused.
He wrote:
Excellent. I remain terrified of you.
I laughed.
Then deleted the email after retention rules allowed? Better email in work account subject to retention. I did not delete manually.
Systems.
Then my team built a medication-safety simulation.
One scenario involved:
a patient with low glucose,
an insulin order,
conflicting family statements.
Someone suggested:
make the spouse malicious.
I said no.
Most errors are not crimes.
A useful simulation should teach:
verify order,
assess patient,
treat hypoglycemia,
clarify medication ownership,
escalate.
Not:
catch villain.
Then a younger nurse asked me after training:
“Was the Moretti thing the scariest thing you ever saw?”
I thought of:
a postpartum hemorrhage,
a septic patient,
a child in respiratory arrest,
my mother’s falls,
Helen forgetting her own sister.
“No.”
She looked surprised.
“Why not?”
“Because I could see the insulin pen.”
The invisible problems were often harder.
A missed message.
A wrong assumption.
A silent patient.
A staffing gap.
An unchecked dose.
Intentional harm is terrifying.
Systems that let ordinary errors repeat can hurt more people.
Then I said:
“But it taught me not to assume wealth creates safety.”
She nodded.
Then:
“Did he really have three armed guards?”
“Yes.”
“Cool.”
“No.”
She laughed.
Young.
Then another lesson.
Our safety team investigated a nurse who had overridden a barcode warning to give insulin.
At first glance:
danger.
Context:
barcode scanner had failed,
patient’s blood glucose was high,
order was correct,
two-nurse manual verification completed,
downtime process allowed.
The override was appropriate.
If we treated every deviation as wrongdoing, staff would hide deviations.
Controls need judgment.
Then an actual misconduct case happened.
A nurse documented glucose checks she had not performed.
Evidence:
device logs,
camera timing,
admission.
She had been overwhelmed and backfilled values from memory.
No patient injury that time.
Still serious.
She was terminated after investigation and reported as required.
Just culture is not no-accountability culture.
That phrase became one I used too often.
My staff mocked me.
Fair.
Then my mother developed type 2 diabetes.
Diet-controlled at first.
Later metformin.
At eighty-four, her A1c rose and physician discussed basal insulin as one option if oral therapy became insufficient.
My chest tightened.
Insulin.
My mother looked at me.
“Don’t.”
“I didn’t say anything.”
“Your face did.”
The physician explained options.
Margaret chose another oral medication first.
Months later, insulin still became appropriate.
A low-dose basal pen.
Legitimate.
Needed.
My mother learned to use it.
I watched the diabetes educator teach:
dial,
prime,
inject,
hold,
dispose needle.
The same shape.
Different truth.
I realized I had spent years teaching people that an insulin pen was not evidence by itself.
Now my own body had to learn the lesson.
Medication is not moral.
Use is.
Consent is.
Indication is.
Dose is.
Process is.
My mother injected herself at the kitchen table and said:
“That’s it?”
“That’s it.”
Then:
“You look pale.”
“I’m fine.”
She laughed.
I deserved that.
After the Raymond Cole review, I added one question to leadership meetings:
“What fact, if wrong, would change our conclusion most?”
It became irritating.
That was why I kept it.
In Raymond’s case:
the assumption that the unlisted lispro belonged to him.
In Luca’s case years earlier:
the assumption that Vanessa’s “metabolic support” came from a legitimate order.
Safety improves when teams identify which assumptions are carrying the most weight.
May you like
Not every investigation needs more data.
Sometimes it needs one assumption exposed to daylight.
